Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease
✍ Scribed by Onofre Combarros; Marisa Sánchez-Guerra; Jon Infante; Javier Llorca; José Berciano
- Publisher
- Springer
- Year
- 2002
- Tongue
- English
- Weight
- 161 KB
- Volume
- 249
- Category
- Article
- ISSN
- 0340-5354
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## 817 ated with increased risk for AD, at least in the Korean population. Nevertheless, it cannot be excluded that the association between IL-1A (-889) C/T polymorphism and AD observed in previous studies might be the result of linkage disequilibrium with a yet unidentified gene on chromosome 2.
## Abstract Recently, a dinucleotide repeat polymorphism was identified in the promoter of the nonamyloid component of plaques (NACP) gene, and it was shown that the NACP allele 2 was significantly associated with healthy elderly control individuals with at least one apolipoprotein E ε4 allele, sug
## Abstract Accumulating evidence indicates that the heparan‐sulfate‐proteoglycan (perlecan, HSPG2), as well as other specific proteoglycans, are involved in amyloidogenesis and tau aggregation in Alzheimer's disease (AD). Moreover, the HSPG2 is located on chromosome 1p36, a region of linkage to la